About Optos (LON:OPTS)
Optos plc is a medical technology company, which is engaged in the design, development, manufacturing and marketing of ultra-wide field (UWF) retinal imaging devices. The Company provides devices to eye care professionals. Its products, Daytona and California, represents its UWF retinal imaging technology, and have been converted to desktop models. Its devices include image modalities, such as color, red-free and auto fluorescence (AF). In addition, the Daytona plus device comes with the OptosAdvance browser-based image review software, which allows for documentation, monitoring and referral processing to assist in patient management. California features fluorescein angiography (FA) and UWF imaging modality, indocyanine green angiography. The Company's devices produce UWF digital images (optomap) of approximately 82% or 200 degree of the retina. Its imaging devices for disease management and treatment support ophthalmologists and retinal specialists in the medical care market.
Industry, Sector and Symbol
Industry Medical Equipment
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Trailing EPSGBX 0.07
Return on Equity11.38%
Return on Assets6.88%
Optos (LON:OPTS) Frequently Asked Questions
What is Optos' stock symbol?
Optos trades on the London Stock Exchange (LON) under the ticker symbol "OPTS."
Who are some of Optos' key competitors?
Some companies that are related to Optos include Roche (ROG), Sanofi (SAN), Bayer (BAYN), CSL (CSL), GlaxoSmithKline (GSK), AstraZeneca (AZN), Covidien (COV), Beximco Pharmaceuticals (BXP), Shire (SHP), Essilor International (EI), C R Bard (BCR), Medivation (MDVN), Ramsay Health Care (RHC), CareFusion (CFN), AEGON (AGN), Bioverativ (BIVV), Cochlear (COH) and Salix Pharmaceuticals (SLXP).
Has Optos been receiving favorable news coverage?
Press coverage about OPTS stock has trended somewhat positive on Tuesday, Accern reports. Accern identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Optos earned a media sentiment score of 0.06 on Accern's scale. They also assigned press coverage about the company an impact score of 45.95 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next several days.
How do I buy shares of Optos?
Shares of OPTS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
How can I contact Optos?
Optos' mailing address is Queensferry House Carnegie Campus, Enterprise Way, DUNFERMLINE, KY11 8GR, United Kingdom. The company can be reached via phone at +44-1383-843300.
MarketBeat Community Rating for Optos (OPTS)MarketBeat's community ratings are surveys of what our community members think about Optos and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Optos (LON:OPTS) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Earnings History for Optos (LON:OPTS)
No earnings announcements for this company have been tracked by MarketBeat.com
Optos (LON:OPTS) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Optos (LON:OPTS)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Optos (LON OPTS)
No insider trades for this company have been tracked by MarketBeat.com
Optos (LON OPTS) News Headlines
Optos (LON:OPTS) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Optos (LON OPTS) Stock Chart for Tuesday, March, 20, 2018